跳至主要内容
临床试验/NL-OMON33540
NL-OMON33540已完成不适用

Among IVF patients undergoing fixed antagonist protocols with recombinant FSH, does administration of recombinant FSH from cycle day 5 onwards compared with cycle day 2 onwards, yield a higher number of good quality embryos? - Comparing start stimulation cycle day 2 versus cycle day 5 in IVF

niversitair Medisch Centrum Utrecht0 个研究点目标入组 117 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
117

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Female age < 39 years
  • FSH < 12 IU/l
  • BMI 18-29 kg/m2
  • Regular cycle (25-35 days)
  • No major uterine or ovarian abnormalities
  • No previous IVF cycles
  • Written informed consent

排除标准

  • Oocyte donation
  • Medical contra indication for pregnancy or IVF treatment
  • Endometriosis >= grade 3
  • Polycystic Ovarium Syndrome (PCOS)
  • Endocrine or metabolic abnormalities (pituitary, adrenal, pancreas, liver or kidney)

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验

进行中(未招募)
不适用
Among non-IVF patients undergoing ovulation induction with clomiphene citrate (Clomid® 50 mg) and having no reaction at day 13 of the cycle, does administration of an increased dose of clomiphene citrate (Clomid® 100 mg) compared with gonadotropins, achieve similar rates of folliculogenesis?The purpose of the present study is to analyse prospectively if highly purified hMG compared with increased dose of clomiphene citrate has different outcomes in folliculogenesis in ovulation induction cycles.
EUCTR2008-006372-29-BEBlockeel Christophe40
终止
4 期
Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cycle Day 5 in In Vitro Fertilization (IVF)in Vitro FertilizationOvulation Induction
NCT00823472UMC Utrecht147
招募中
2 期
Evaluation of IVF Outcomes in Patients with Decreased Ovarian reserve with Double Stimulation Compared with conventional Antagonist Cycle
IRCT20120817010617N8Zahedan University of Medical Sciences54
已完成
3 期
Evaluating the Effects of GnRH agonist (0.1, 0.2, and 0.3 diphereline) in triggering of final oocyte maturation in infertile womeInfertility.Female infertility
IRCT20190409043212N2Shiraz University of Medical Sciences150
进行中(未招募)
不适用
Does an innovative method of sequencing, known as next generation sequencing (NGS), applied for normal embryo selection in infertile patients improve pregnancy rate in fresh transfer?embryo aneuploidyReproductive Health and Childbirth - Fertility including in vitro fertilisationinfertility
ACTRN12614001035617Invicta s. z o.o.98